Piero Parchi is an expert in Neurology at Istituto delle Scienze Neurologiche di Bologna (Italy). As of October 2026, ScienceLeadR ranks Piero Parchi in the top 1% of experts worldwide for Creutzfeldt-Jakob Syndrome and Dementia. Piero Parchi has authored 358 publications, the most recent in 2026. SLR score: 1,280 (community average: 125). How the SLR is computed.

LeadR Profile

1 280 ScienceLeadR Reputation 1280
Network Map

Neurology

Subspecialties: Biochemistry - Psychiatry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026

Source: PubMed

University of Bologna

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 358

Citations

Citations: 19 801 1st author: 24 Last author: 100 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Variably protease-sensitive prionopathy in the context of a complex proteinopathy: clinical and neuropathological challenges.
PMID 42953028 — genes, codon, pathology, prions, signs and symptoms, cerebellum, peptide hydrolases, genotype, frontotemporal lobar degeneration, prion diseases
Front Neurosci20260
Longitudinal Real-Time Quaking-Induced Conversion Analysis of Misfolded α-Synuclein in Idiopathic Rapid Eye Movement Sleep Behavior Disorder Patients with Baseline Cerebrospinal Fluid Negativity.
PMID 42947475 — parkinson disease, rem sleep behavior disorder, sleep, spinal puncture, synucleinopathies, movement disorders, tomography, emission-computed, single-photon, eye movements, synucleins, movement
Mov Disord20260
A two-step processing method is recommended to inactivate human sporadic M1 and V2 prions.
PMID 42747978 — sterilization, virology, prions, therapeutics, infections
J Gen Virol20260
Alterations of gut microbiota in Down syndrome and their association with Alzheimer's disease.
PMID 42712102 — dementia, down syndrome, alzheimer disease, biomarkers, metagenomics, gastrointestinal microbiome, microbiota, plasma
Alzheimers Dement20260
Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.
PMID 42690439 — amyloid beta-peptides, alzheimer disease, brain, pathology, prions, biomarkers, amyloid, neurology, plasma
Acta Neuropathol20260

LeadR Networks

Main global connection map